South Africa is leading a transformative initiative to modernise the healthcare market in Africa, tackling one of the continent’s most persistent challenges: inefficient pharmaceutical supply chains. The healthcare market in Africa, valued at $26.85 billion in 2023, is projected to grow at 3.4% annually through 2030. Yet the industry’s potential remains hampered by fragmented supply chains, infrastructure gaps, and regulatory inconsistencies.
A new pilot programme, led by Prosper Africa’s Tech for Trade Alliance (AT4T), seeks to overcome these barriers. The initiative introduces Pulse by NABP, a digital platform designed to improve transparency and efficiency in the distribution of medicines. By linking pharmacies and distributors with global pharmaceutical companies like Pfizer and Roche, the platform aims to ensure patients have consistent access to safe, affordable medications.
No ad to show here.
“This initiative embodies the potential of public-private collaboration,” said British Robinson, Coordinator of Prosper Africa. “Through innovative technology, we aim to create financial and social returns for Africans and Americans alike.”
Tech-Driven Solutions for Healthcare
The pilot is supported by USAID’s e-Trade Alliance, IBM Consulting, and the National Association of Boards of Pharmacy (NABP). At its core, Pulse by NABP leverages AI-powered tools, including IBM’s watsonx.ai, to enable pharmacies to track medication origins, verify authenticity, and optimise inventory in real time.
“By leveraging AI and data, we aim to create a secure, transparent environment that enables pharmacies and distributors to make more informed, data-driven decisions,” said Riaz Osman, Managing Partner at IBM Consulting Southern Africa.
This data-driven approach addresses longstanding inefficiencies in Africa’s healthcare market, helping to reduce wastage, prevent counterfeit drugs, and improve trust between providers and patients.
The Challenges in Africa’s Healthcare Market
The fragmented nature of Africa’s healthcare market creates challenges that ripple across the continent. Rural pharmacies often struggle with stock management, leading to inconsistent availability of essential medicines. Meanwhile, counterfeit drugs continue to infiltrate the market, endangering patient safety and eroding public trust.
For South Africa, this pilot represents a crucial opportunity to demonstrate how technology can address these systemic issues. “Greater transparency not only improves operational efficiency but also enhances public trust in the quality and safety of medicines,” explained Lemrey “Al” Carter, Executive Director of NABP.
Economic and Social Impact
The pilot’s benefits extend beyond operational improvements. Pharmacies across Africa can monetise their operational data by using AI tools to develop more effective sales strategies. Meanwhile, global pharmaceutical companies gain clearer insights into market dynamics, enabling more strategic investments.
As one of the continent’s most technologically advanced nations, South Africa is an ideal testing ground for solutions that could eventually scale to other parts of Africa. The project could become a blueprint for addressing challenges in other sectors, from agriculture to energy.
Collaboration as a Catalyst
The partnership between Prosper Africa, IBM, and NABP underscores the potential of public-private collaboration to drive systemic change. Prosper Africa, a U.S. government initiative involving 17 federal agencies, facilitates such partnerships to create economic and social value on both sides of the Atlantic.
“By fostering collaboration, we’re building resilient ecosystems that benefit patients, businesses, and economies alike,” said Robinson.
